Key Dates

Related Announcements

• May 10, 2021 - "Development & Testing of Novel Interventions to improve HIV Prevention, Treatment, and Program Implementation for People Who Use Drugs (R34 Clinical Trial Required)" See NOFO PA-21-205

Issued by

National Institute on Drug Abuse (NIDA)

Purpose

The purpose of this Notice is to add additional application receipt date in 2024, to the list of application due dates, for PA-21-205, "Development & Testing of Novel Interventions to improve HIV Prevention, Treatment, and Program Implementation for People Who Use Drugs (R34 Clinical Trial Required)" 

Key Dates

Currently reads:

All applications are due by 5:00 PM local time of applicant organization.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Expiration Date

May 8, 2024

Modified to read (in Bold italics):

All applications are due by 5:00 PM local time of applicant organization.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Expiration Date

January 8, 2025

All other aspects of the NOFO remain the same.

Inquiries

Please direct all inquiries to:

Richard A. Jenkins, PhD
National Institute on Drug Abuse (NIDA)
Telephone: 301-443-1923
Email: jenkinsri@mail.nih.gov

Angela Lee-Winn, PhD
National Institute on Drug Abuse (NIDA)
Telephone: 301-451-7206
Email: angela.lee-winn@nih.gov

Raul N. Mandler, MD
National Institute on Drug Abuse (NIDA)
Telephone: 301-480-2541
Email: mandlerr@mail.nih.gov